Description

Theophylline, 8-Chloro-, Compd. With 2-(1,1-Diphenylethoxy)-N,n-Dimethylethylamine (1:1) is a specialized pharmaceutical salt complex designed to enhance the stability and bioavailability of the active theophylline derivative. This compound is critical for formulators seeking to develop advanced respiratory and bronchodilator medications with improved pharmacokinetic profiles. It is primarily utilized by pharmaceutical R&D departments and fine chemical manufacturers serving the global healthcare sector.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of advanced bronchodilator and anti-asthma drug formulations.
• Respiratory Therapy Research: Used in preclinical and clinical research for developing new treatments for chronic obstructive pulmonary disease (COPD) and asthma.
• Controlled-Release Drug Development: Employed in the design of sustained-release oral dosage forms to maintain therapeutic drug levels over extended periods.
• Reference Standard: Acts as a high-purity analytical standard for quality control and regulatory testing in pharmaceutical manufacturing.
• Metabolite Studies: Utilized in pharmacological studies to investigate the metabolism and activity of chlorinated theophylline derivatives.

Basic Information

Product Name	Theophylline, 8-Chloro-, Compd. With 2-(1,1-Diphenylethoxy)-N,n-Dimethylethylamine (1:1)
CAS No.	21661-62-1
Molecular Formula	C23H29ClN4O3 • C18H23NO
Molecular Weight	Contact for details
Synonyms	8-Chlorotheophylline Diphenidol Salt; 8-Chlorotheophylline Compd. with 2-(1,1-Diphenylethoxy)-N,N-Dimethylethylamine; 1H-Purine-2,6-dione, 8-chloro-3,7-dihydro-1,3-dimethyl-, compd. with 2-[1,1-diphenylethoxy]-N,N-dimethylethanamine (1:1); Theophylline, 8-chloro-, compound with 2-(1,1-diphenylethoxy)-N,N-dimethylethylamine (1:1); Diphenidol 8-Chlorotheophyllinate
EINECS	Contact for details

Quality Control

Our Theophylline, 8-Chloro-, Compd. With 2-(1,1-Diphenylethoxy)-N,n-Dimethylethylamine (1:1) is manufactured under strict quality systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical development. Certificates of Analysis (COA) detailing all specifications are available upon request to support your regulatory and quality assurance processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.